Common Contracts
2 similar Credit Agreement contracts by Catalent, Inc.
AMENDMENT NO. 10 TO AMENDED AND RESTATED CREDIT AGREEMENTCredit Agreement • November 27th, 2023 • Catalent, Inc. • Pharmaceutical preparations • New York
AMENDMENT NO. 10 TO AMENDED AND RESTATED CREDIT AGREEMENT, dated as of November 22, 2023 (this “Amendment”), by and among CATALENT PHARMA SOLUTIONS, INC., a Delaware corporation (the “Borrower”), PTS INTERMEDIATE HOLDINGS LLC, a Delaware limited liability company (“Holdings”), the SUBSIDIARY GUARANTORS and the Lenders party hereto (which constitute the Required Lenders (as defined in the Existing Credit Agreement (as defined below)). Capitalized terms not otherwise defined in this Amendment have the same meanings as specified in the Existing Credit Agreement referred to below.
AMENDMENT NO. 9 TO AMENDED AND RESTATED CREDIT AGREEMENTCredit Agreement • September 28th, 2023 • Catalent, Inc. • Pharmaceutical preparations • New York
AMENDMENT NO. 9 TO AMENDED AND RESTATED CREDIT AGREEMENT, dated as of September 27, 2023 (this “Amendment”), by and among CATALENT PHARMA SOLUTIONS, INC., a Delaware corporation (the “Borrower”), PTS INTERMEDIATE HOLDINGS LLC, a Delaware limited liability company (“Holdings”), the SUBSIDIARY GUARANTORS and the Lenders party hereto (which constitute the Required Lenders (as defined in the Existing Credit Agreement (as defined below)). Capitalized terms not otherwise defined in this Amendment have the same meanings as specified in the Existing Credit Agreement referred to below.
